1.IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity

Huang, Xuan, Kuerban     More...

Huang, Xuan, Kuerban, Kudelaidi, Fan, Jajun, Pan, Danjie, Chen, Huaning, Liu, Jiayang, Wang, Songna, Ju, Dianwen, Zhu, Yi Zhun, Liu, Jiyong, Ye, Li     Less

Asian Journal Pharmaceutical Sciences[1818-0876], Published 2025, Volume 20, Issue 2,

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2024影響因子:  11.9 

2.Recombinant CD80 fusion protein combined with discoidin domain receptor 1 inhibitor for cancer treatment

Wang, SN, Hu, PL, Zh     More...

Wang, SN, Hu, PL, Zhang, XY, Fan, JJ, Zou, J, Hong, WD, Huang, X, Pan, DJ, Chen, HN, Ju, DW, Zhu, YZ, Ye, L     Less

Applied Microbiology and Biotechnology[0175-7598], Published 2025, Volume 109, Issue 1, Pages 39

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2024影響因子:  4.3 

3.A superior method for antitumor therapy and application: dual-ligand nanomedicines

Wang, AL, Wang, XJ,     More...

Wang, AL, Wang, XJ, Li, D, Li, AX, He, MY, Yuan, YY, Ye, L, Liu, JY     Less

JOURNAL OF MATERIALS CHEMISTRY B[2050-750X], Published 2025,

收錄情况： WOS SCOPUS

WOS核心合集引用: 4  2024影響因子:  5.7 

4.In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity

Pan, DJ, Du, L, Liu,     More...

Pan, DJ, Du, L, Liu, JY, Kuerban, K, Huang, X, Wang, Y, Guo, QY, Chen, HN, Wang, SN, Wang, L, Zhou, PH, Meng, ZF, Ye, L     Less

VACCINES[2076-393X], Published 2025, Volume 13, Issue 7,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2024影響因子:  3.4 

5.DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma

Huang, X, Jing, GJ,     More...

Huang, X, Jing, GJ, Kuerban, K, Fan, JJ, Yu, M, Yang, SL, Chen, W, Huang, LT, Ju, DW, Zhu, YZ, Ye, L     Less

International Journal of Molecular Sciences[1661-6596], Published 2025, Volume 26, Issue 16, Pages 7731

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2024影響因子:  4.9 

6.Anti-angiogenesis enhances the tumor immunotherapeutical effect of recombinant CD80 fusion protein

Wang, SN, Huang, LT,     More...

Wang, SN, Huang, LT, Zhang, XY, Fan, JJ, Zou, J, Hong, WD, Tuerdi, A, Zhu, YZ, Hu, PL, Ye, L     Less

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES[0141-8130], Published 2025, Volume 321,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2024影響因子:  8.5 

7.CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications

Cai, MH, Zhou, XX, W     More...

Cai, MH, Zhou, XX, Wang, SN, Huang, X, Chen, W, Chen, YL, Huang, LT, Yan, Y, Zhu, YZ, Ye, L     Less

International Journal of Molecular Sciences[1661-6596], Published 2025, Volume 26, Issue 17,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2024影響因子:  4.9 

8.Bioengineered In Situ-Forming Hydrogels as Smart Drug Delivery Systems for Postoperative Breast Cancer Immunotherapy: From Material Innovation to Clinical Translation

Yan, Y, Chen, YL, Hu     More...

Yan, Y, Chen, YL, Huang, LT, Cai, MH, Yin, X, Zhu, YZ, Ye, L     Less

Journal of Functional Biomaterials[2079-4983], Published 2025, Volume 16, Issue 10,

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2024影響因子:  5.2 

9.The many faces of Interleukin-27 in liver diseases: from immune regulator to metabolic player

Zhou, Xiaoxi, Qu, He     More...

Zhou, Xiaoxi, Qu, Hengdong, Cui, Yiming, Zhou, Wenfang, Wang, Qian, Yang, Hengwen, Hong, Jian, Ye, Li, Yin, Zhinan     Less

Life Sciences[0024-3205], Published 2025, Volume 383,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2024影響因子:  5.1 

10.CD80-Fc fusion protein as a potential cancer immunotherapy strategy

Wang, Songna, Hu, Pi     More...

Wang, Songna, Hu, Pinliang, Fan, Jiajun, Zou, Jing, Hong, Weidong, Huang, Xuan, Pan, Danjie, Chen, Huaning, Zhu, Yi Zhun, Ye, Li     Less

Antibody Therapeutics[2516-4236], Published 2024, Volume 7, Issue 1, Pages 28-36

收錄情况： WOS SCOPUS

WOS核心合集引用: 6  2024影響因子:  4.5  发表年影響因子:  4.5 

11.Challenges and New Directions in Therapeutic Cancer Vaccine Development

Pan, DJ, Liu, JY, Hu     More...

Pan, DJ, Liu, JY, Huang, X, Wang, SN, Kuerban, K, Yan, Y, Zhu, YZ, Ye, L     Less

VACCINES[2076-393X], Published 2024, Volume 12, Issue 12,

收錄情况： WOS SCOPUS

WOS核心合集引用: 5  2024影響因子:  3.4  发表年影響因子:  3.4 

12.Research progress of interleukin-15 in cancer immunotherapy

Cai, Menghan, Huang,     More...

Cai, Menghan, Huang, Xuan, Huang, Xiting, Ju, Dianwen, Zhu, Yi Zhun, Ye, Li     Less

Frontiers in Pharmacology[1663-9812], Published 2023, Volume 14,

收錄情况： WOS SCOPUS

WOS核心合集引用: 56  2024影響因子:  4.8  发表年影響因子:  4.4 

13.A collagen-binding SIRPαFc fusion protein for targeted cancer immunotherapy

Liu, JY, Xu, TY, Pan     More...

Liu, JY, Xu, TY, Pan, DJ, Fan, JJ, Huang, XT, Zhao, WL, Dong, XC, Zhang, SH, Kuerban, K, Huang, X, Wang, SN, Chen, HN, He, YP, Zhu, YZ, Wang, CJ, Ye, L     Less

INTERNATIONAL IMMUNOPHARMACOLOGY[1567-5769], Published 2023, Volume 124,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2024影響因子:  4.7  发表年影響因子:  4.8 

14.DKK1 Promotes Epithelial-Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway

Li, J, Zhang, YQ, Ye     More...

Li, J, Zhang, YQ, Ye, FZ, Qian, PY, Qin, Z, Li, DM, Ye, L, Feng, L     Less

CANCERS[2072-6694], Published 2023, Volume 15, Issue 19,

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2024影響因子:  4.4  发表年影響因子:  4.5 

15.Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy

Liu, JY, Pan, DJ, Hu     More...

Liu, JY, Pan, DJ, Huang, X, Wang, SN, Chen, HN, Zhu, YZ, Ye, L     Less

FRONTIERS IN ONCOLOGY[2234-943X], Published 2023, Volume 13,

收錄情况： WOS SCOPUS

WOS核心合集引用: 13  2024影響因子:  3.3  发表年影響因子:  3.5 

16.Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer

Wang, SN, Fu, Y, Kue     More...

Wang, SN, Fu, Y, Kuerban, K, Liu, JY, Huang, X, Pan, DJ, Chen, HN, Zhu, YZ, Ye, L     Less

FRONTIERS IN IMMUNOLOGY[1664-3224], Published 2022, Volume 13,

收錄情况： WOS SCOPUS

WOS核心合集引用: 17  2024影響因子:  5.9  发表年影響因子:  7.3 

17.Disruption of Wnt/beta-catenin Pathway Elevates the Sensitivity of Gastric Cancer Cells to PD-1 Antibody

Li, J, Zhang, H, Bei     More...

Li, J, Zhang, H, Bei, SH, Zhang, XH, Li, HQ, Ye, L, Feng, L     Less

CURRENT MOLECULAR PHARMACOLOGY[1874-4672], Published 2022, Volume 15, Issue 3, Pages 557-569

收錄情况： WOS SCOPUS

WOS核心合集引用: 15  2024影響因子:  2.9  发表年影響因子:  2.7 

18.A SIRP alpha Fc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer

Liu, JY, Meng, ZF, X     More...

Liu, JY, Meng, ZF, Xu, TY, Kuerban, K, Wang, SN, Zhang, XY, Fan, JJ, Ju, DW, Tian, WZ, Huang, X, Huang, XT, Pan, DJ, Chen, HN, Zhao, WL, Ye, L     Less

FRONTIERS IN IMMUNOLOGY[1664-3224], Published 2022, Volume 13, Pages 845217

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2024影響因子:  5.9  发表年影響因子:  7.3 

19.Wnt/β-catenin信号通路与癌症发生发展及其免疫治疗

张慧,陈华宁,库德莱迪·库尔班,王松娜,     More...

张慧,陈华宁,库德莱迪·库尔班,王松娜,刘嘉扬,赵缜,叶丽     Less

中国生物工程杂志[1671-8135], Published 2022, Volume 42, Issue Z1, Pages 104-111

收錄情况： SCOPUS CNKI

20.Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW264.7 macrophages by promoting TNF-alpha, IL-6 and MHC-II expression

Jiang, SS, Wang, R,     More...

Jiang, SS, Wang, R, Han, L, Kuerban, K, Ye, L, Pan, S, Li, SN, Yuan, YF     Less

IMMUNOLOGIC RESEARCH[0257-277X], Published 2021, Volume 69, Issue 4, Pages 352-362

收錄情况： WOS SCOPUS

WOS核心合集引用: 20  2024影響因子:  3.1  发表年影響因子:  4.505